ArticleFrontiers in oncology2025

Impact of prior immunotherapy on paclitaxel/bevacizumab in advanced non-squamous non-small cell lung cancer.

Agathe Peyret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.